Devising a new auditing regime at the eleventh hour

Article Abstract:

Norman Marks, Solectron's vice-president of internal audit, states that the company uses a mix of its own staff and outside consulting hires to get the bulk of the financial testing done. This is because the range of specialties needed requires the service of six outside consulting firms.

ELECTRONIC & OTHER ELECTRIC EQUIPMENT, Executive changes & profiles, Capital funds & cash flow, Officials and employees, Accounting and auditing, Beliefs, opinions and attitudes, Electronics industry, Solectron Corp., SLR, Accounting law, Marks, Norman

---

Policing payroll - ACL adds to its audit offerings

Article Abstract:

ACL Services Ltd. has introduced a new browser-based software called CCM for Payroll that is useful for controlling fraud in the payroll processes of an organization. The new software is described in brief.

Prepackaged software, Product introduction, New Products/Services, Computer software industry, Software industry, Payroll processing software, Payrolls, Payroll software, ACL Services Ltd., CCM for Payroll (Payroll software)

---

A wish list to vendors prompts innovation

Article Abstract:

The details on LIN TV Corp., which adopted accounting software, are presented.

Television Broadcasting, Television broadcasting stations, Usage, Television broadcasting industry, Technology application, Accounting software, Integrated accounting software, LIN Television Corp.

Similar abstracts:

• Abstracts: Breaking with the bank. Facing the CLS liquidity challenge. Firms fail to follow the money
• Abstracts: Constructing competitive advantage: the role of firm-constituent interactions. Believing one's own press: the causes and consequences of CEO celebrity
• Abstracts: A very firm handshake: Biotech's growing negotiating power. China steps towards international M&A. Sumitomo buys Oxford Finance
• Abstracts: Client expense accounting becomes more complex. Planning to propose in '06-part II. Home office deduction revisited
• Abstracts: Europe caught in innovation quagmire. Antibodies' long revenue stream spurs pharma acquisitions. Sanofi takeover jeopardizes Aventis biotech deals

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.